BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32451408)

  • 1. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
    Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
    Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINC00491 accelerates head and neck squamous cell carcinoma progression through regulating miR-508-3p/SATB1 axis and activating Wnt signaling pathway.
    Cui D; Li Z; Wei C; Zhang Q; Xiao C
    Cytokine; 2024 Mar; 175():156444. PubMed ID: 38150791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
    Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
    J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory Upregulation of Other HER Family Members: Basis for Acquired Resistance and for Combination Therapy.
    Gutsch D; Jenke R; Büch T; Aigner A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
    Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
    PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.
    Zhang L; Li Z; Liu Y; Xu S; Tandon M; Appelboom B; LaValle CR; Chiosea SI; Wang L; Sen M; Lui VWY; Grandis JR; Wang QJ
    BMC Cancer; 2018 Nov; 18(1):1107. PubMed ID: 30419840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.
    Wang D; Müller S; Amin AR; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z; Tighiouart M; Shin DM; Chen ZG
    Clin Cancer Res; 2012 Sep; 18(17):4589-99. PubMed ID: 22829201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models.
    Harms JK; Lee TW; Wang T; Lai A; Kee D; Chaplin JM; McIvor NP; Hunter FW; Macann AMJ; Wilson WR; Jamieson SMF
    Cells; 2019 Jul; 8(7):. PubMed ID: 31337055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of SATB1 in Tumour Progression and Metastasis.
    Glatzel-Plucińska N; Piotrowska A; Dzięgiel P; Podhorska-Okołów M
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.
    Beyer M; Thabet Y; Müller RU; Sadlon T; Classen S; Lahl K; Basu S; Zhou X; Bailey-Bucktrout SL; Krebs W; Schönfeld EA; Böttcher J; Golovina T; Mayer CT; Hofmann A; Sommer D; Debey-Pascher S; Endl E; Limmer A; Hippen KL; Blazar BR; Balderas R; Quast T; Waha A; Mayer G; Famulok M; Knolle PA; Wickenhauser C; Kolanus W; Schermer B; Bluestone JA; Barry SC; Sparwasser T; Riley JL; Schultze JL
    Nat Immunol; 2011 Aug; 12(9):898-907. PubMed ID: 21841785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
    Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and CTCF in HNSCC cells.
    Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
    Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satb1 integrates DNA binding site geometry and torsional stress to differentially target nucleosome-dense regions.
    Ghosh RP; Shi Q; Yang L; Reddick MP; Nikitina T; Zhurkin VB; Fordyce P; Stasevich TJ; Chang HY; Greenleaf WJ; Liphardt JT
    Nat Commun; 2019 Jul; 10(1):3221. PubMed ID: 31324780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN
    Stueven NA; Beauvais DM; Hu R; Kimple RJ; Rapraeger AC
    Cancer Res Commun; 2023 Jan; 3(1):97-108. PubMed ID: 36968227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo.
    Alonso-Valenteen F; Pacheco S; Srinivas D; Rentsendorj A; Chu D; Lubow J; Sims J; Miao T; Mikhael S; Hwang JY; Abrol R; Medina Kauwe LK
    Nucleic Acids Res; 2019 Dec; 47(21):11020-11043. PubMed ID: 31617560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.
    Liu H; Huang Y; Li Z; Han S; Liu T; Zhao Q
    Front Immunol; 2023; 14():1343428. PubMed ID: 38274829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma.
    PLOS ONE Editors
    PLoS One; 2024; 19(4):e0301571. PubMed ID: 38564511
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
    PLOS ONE Editors
    PLoS One; 2024; 19(4):e0301572. PubMed ID: 38564501
    [No Abstract]   [Full Text] [Related]  

  • 19. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains.
    Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N
    Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Dietz A; Meyer HJ
    Chirurg; 2020 Nov; 91(11):978. PubMed ID: 33094380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.